What is microglia neurotoxicity (Not)?

GLIA

Volumn 62, Issue 6, 2014, Pages 841-854

  Biber, Knut ^a,b   Owens, Trevor ^c   Boddeke, Erik ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Activation states; Microglia evolution; Neuroinflammation; Neuronal loss

Indexed keywords

CD200 ANTIGEN; CD200 RECEPTOR; CHEMOKINE RECEPTOR CX3CR1; CLODRONIC ACID; FRACTALKINE;

AGING; BONE MARROW CELL; CELL ACTIVATION; CELL FUNCTION; CELL KILLING; CELL STRUCTURE; EMBRYO DEVELOPMENT; GENE DELETION; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; MONOCYTE; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; REVIEW; ANIMAL; BRAIN; CHEMISTRY; METABOLISM; NERVOUS SYSTEM DISEASES; PATHOLOGY;

AGING; ANIMALS; BRAIN; HUMANS; MICROGLIA; NERVOUS SYSTEM DISEASES; NEURONS;

EID: 84898028606     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22654     Document Type: Review

References (175)

1. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ. 2003. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100:7947-7952.
2. Aguzzi A, Barres BA, Bennett ML. 2013. Microglia: scapegoat, saboteur, or something else? Science 339:156-161.
3. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14:1142-1149.
4. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. 2007. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10:1538-1543.
5. Ajmone-Cat MAM, Mancini R, De Simone PC, Minghetti L. 2013. Microglial polarization and plasticity: Evidence from organotypic hippocampal slice cultures. Glia 61:1698-1711.
6. Allen NJ, Barres BA. 2009. Neuroscience: Glia - more than just brain glue. Nature 457:675-677.
7. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103:16021-16026.
8. Benkovic SA, O'Callaghan JP, Miller DB. 2004. Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures. Brain Res 1024:59-76.
9. Beutner C, Linnartz-Gerlach B, Schmidt SV, Beyer M, Mallmann MR, Staratschek-Jox A, Schultze JL, Neumann H. 2013. Unique transcriptome signature of mouse microglia. Glia 61:1429-1442.
10. Biber K, Neumann H, Inoue K, Boddeke HW. 2007. Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci 30:596-602.
11. Bishop NA, Lu T, Yankner BA. 2010. Neural mechanisms of ageing and cognitive decline. Nature 464:529-535.
12. Block ML, Zecca L, Hong JS. 2007. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci 8:57-69.
13. Boche D, Perry VH, Nicoll JA. 2013. Review: Activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39:3-18.
14. Boillée S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389-1392.
15. Boje KM, Arora PK. 1992. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587:250-256.
16. Boucsein C, Kettenmann H, Nolte C. 2000. Electrophysiological properties of microglial cells in normal and pathologic rat brain slices. Eur J Neurosci 12:2049-2058.
17. Broderick C, Hoek RM, Forrester JV, Liversidge J, Sedgwick JD, Dick AD. 2002. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol 161:1669-1677.
18. Buiting AM, Van Rooijen N. 1994. Liposome mediated depletion of macrophages: An approach for fundamental studies. J Drug Target 2:357-362.
19. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, Joseph B. 2011. Caspase signalling controls microglia activation and neurotoxicity. Nature 472:319-324.
20. Burke SN, Barnes CA. 2010. Senescent synapses and hippocampal circuit dynamics. Trends Neurosci 33:153-161.
21. Cao L, He C. 2013. Polarization of macrophages and microglia in inflammatory demyelination. Neurosci Bull 29:189-198.
22. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM. 2006. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917-924.
23. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149:2736-2741.
24. Chiu IM, Morimoto ET, Goodarzi H, Liao JT, O'Keeffe S, Phatnani HP, Muratet M, Carroll MC, Levy S, Tavazoie S, Myers RM, Maniatis T. 2013. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep 4:385-401.
25. Cho IH, Hong J, Suh EC, Kim JH, Lee H, Lee JE, Lee S, Kim CH, Kim DW, Jo EK, Lee KE, Karin M, Lee SJ. 2008. Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death. Brain 131:3019-3033.
26. Cho SH, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L. 2011. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem 286:32713-32722.
27. Cipriani R, Villa P, Chece G, Lauro C, Paladini A, Micotti E, Perego C, De Simoni MG, Fredholm BB, Eusebi F, Limatola C. 2011. CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci 31:16327-16335.
28. Colonna M. 2003. DAP12 signaling: From immune cells to bone modeling and brain myelination. J Clin Invest 111:313-314.
29. Colton CA. 2009. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 4:399-418.
30. Copray S, Huynh JL, Sher F, Casaccia-Bonnefil P, Boddeke E. 2009. Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging. Glia 15:1579-1587.
31. Crain JM, Nikodemova M, Watters JJ. 2013. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res 91:1143-1151.
32. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. 2005. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 25:9275-9284.
33. de Monasterio-Schrader P, Patzig J, Möbius W, Barrette B, Wagner TL, Kusch K, Edgar JM, Brophy PJ, Werner HB. 2013. Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2. Glia 61:1832-47. doi: 10.1002/glia.22561.
34. Deng YY, Lu J, Ling EA, Kaur C. 2009. Monocyte chemoattractant protein-1 (MCP-1) produced via NF-kappaB signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats. Glia 156:604-621.
35. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV. 2007. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38:1345-1353.
36. Drabek T, Janata A, Jackson EK, End B, Stezoski J, Vagni VA, Janesko-Feldman K, Wilson CD, van Rooijen N, Tisherman SA, Kochanek PM. 2012. Microglial depletion using intrahippocampal injection of liposome-encapsulated clodronate in prolonged hypothermic cardiac arrest in rats. Resuscitation 83:517-526.
37. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115:56-65.
38. Dunston CR, Griffiths HR, Lambert PA, Staddon S, Vernallis AB. 2011. Proteomic analysis of the anti-inflammatory action of minocycline. Proteomics 11:42-51.
39. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD. 2007. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13:432-438.
40. Fan LW, Pang Y, Lin S, Rhodes PG, Cai Z. 2005. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 133:159-168.
41. Faustino JV, Wang X, Johnson CE, Klibanov A, Derugin N, Wendland MF, Vexler ZS. 2011. Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci 31:12992-13001.
42. Fendrick SE, Xue QS, Streit WJ. 2007. Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene. J Neuroinflammation 4:9.
43. Fernández-López D, Faustino J, Derugin N, Wendland M, Lizasoain I, Moro MA, Vexler ZS. 2012. Reduced infarct size and accumulation of microglia in rats treated with WIN 55, 212-2 after neonatal stroke. Neuroscience 207:307-315.
44. Flanary BE, Sammons NW, Nguyen C, Walker D, Streit WJ. 2007. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res 10:61-74.
45. Frotscher M, Zafirov S, Heimrich B. 1995. Development of identified neuronal types and of specific synaptic connections in slice cultures of rat hippocampus. Prog Neurobiol 45:vii-xxviii.
46. Gao HM, Zhou H, Zhang F, Wilson BC, Kam W, Hong JS. 2011. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J Neurosci 31:1081-1092.
47. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841-845.
48. Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW, Norden DM. 2005. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 19:1329-1331.
49. Godbout JP, Johnson RW. 2009. Age and neuroinflammation: A lifetime of psychoneuroimmune consequences. Immunol Allergy Clin North Am 29:321-337.
50. Goldmann T, Wieghofer P, Müller PF, Wolf Y, Varol D, Yona S, Brendecke SM, Kierdorf K, Staszewski O, Datta M, Luedde T, Heikenwalder M, Jung S, Prinz M. 2013. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci 16:1618-1626.
51. Gowing G, Philips T, Van Wijmeersch B, Audet JN, Dewil M, Van Den Bosch L, Billiau AD, Robberecht W, Julien JP. 2008. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci 28:10234-10244.
52. Gowing G, Vallières L, Julien JP. 2006. Mouse model for ablation of proliferating microglia in acute CNS injuries. Glia 53:331-337.
53. Graeber MB. 2010. Changing face of microglia. Science 330:783-788.
54. Graeber MB, Streit WJ. 2010. Microglia: Biology and pathology. Acta Neuropathol 119:89-105.
55. Grathwohl SA, Kälin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, Odenthal J, Radde R, Eldh T, Gandy S, Aguzzi A, Staufenbiel M, Mathews PM, Wolburg H, Heppner FL, Jucker M. 2009. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 12:1361-1363.
56. Hailer NP, Jarhult JD, Nitsch R. 1996. Resting microglial cells in vitro: Analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures. Glia 18:319-331.
57. Hanisch UK. 2013. Functional diversity of microglia-How heterogeneous are they to begin with? Front Cell Neurosci 14;7:65.
58. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387-1394.
59. Hasegawa-Ishii S, Takei S, Chiba Y, Furukawa A, Umegaki H, Iguchi A, Kawamura N, Yoshikawa K, Hosokawa M, Shimada A. 2011. Morphological impairments in microglia precede age-related neuronal degeneration in senescence-accelerated mice. Neuropathology 31:20-28.
60. He Y, Appel S, Le W. 2001. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 909:187-193.
61. Hellwig S, Heinrich A, Biber K. 2013. The brain's best friend: Microglial neurotoxicity revisited. Front Cell Neurosci 16;7:71.
62. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT. 2013. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493:674-678.
63. Henry CJ, Huang Y, Wynne AM, Godbout JP. 2009. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun 23:309-317.
64. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hövelmeyer N, Waisman A, Rülicke T, Prinz M, Priller J, Becher B, Aguzzi A. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11:146-152.
65. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK, El Khoury J. 2013. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. doi: 10.1038/nn.3554.
66. Hinman JD, Abraham CR. 2007. What's behind the decline? The role of white matter in brain aging. Neurochem Res 32:2023-2031.
67. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, Barclay AN, Sedgwick JD. 2000. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290:1768-1771.
68. Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH. 2002. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37:314-327.
69. Hulshof S, van Haastert ES, Kuipers HF, van den Elsen PJ, De Groot CJ, van der Valk P, Ravid R, Biber K. 2003. CX3CL1 and CX3CR1 expression in human brain tissue: Noninflammatory control versus multiple sclerosis. J Neuropathol Exp Neurol 62:899-907.
70. Hunter CL, Bachman D, Granholm AC. 2004. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann Neurol 56:675-688.
71. Jang E, Lee S, Kim JH, Kim JH, Seo JW, Lee WH, Mori K, Nakao K, Suk K. 2013. Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J 27:1176-1190.
72. Jimenez S, Baglietto-Vargas D, Caballero C, Moreno-Gonzalez I, Torres M, Sanchez-Varo R, Ruano D, Vizuete M, Gutierrez A, Vitorica J. 2008. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: Age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci 28:11650-11661.
73. Jung H, Bhangoo S, Banisadr G, Freitag C, Ren D, White FA, Miller RJ. 2009. Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. J Neurosci 29:8051-8062.
74. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:4106-4114.
75. Jung S, Schwartz M. 2012. Non-identical twins-Microglia and monocyte-derived macrophages in acute injury and autoimmune inflammation. Front Immunol 3:89.
76. Kang J, Rivest S. 2007. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J Cell Biol 179:1219-1230.
77. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461-553.
78. Kettenmann H, Kirchhoff F, Verkhratsky A. 2013. Microglia: New roles for the synaptic stripper. Neuron 77:10-18.
79. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, Wieghofer P, Heinrich A, Riemke P, Hölscher C, Müller DN, Luckow B, Brocker T, Debowski K, Fritz G, Opdenakker G, Diefenbach A, Biber K, Heikenwalder M, Geissmann F, Rosenbauer F, Prinz M. 2013. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci 16:273-280.
80. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. 2000. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia. J Neurosci 20:6309-6316.
81. Kohl A, Dehghani F, Korf HW, Hailer NP. 2003. The bisphosphonate clodronate depletes microglial cells in excitotoxically injured organotypic hippocampal slice cultures. Exp Neurol 181:1-11.
82. Koning N, Bö L, Hoek RM, Huitinga I. 2007. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 62:504-514.
83. Koning N, Swaab DF, Hoek RM, Huitinga I. 2009. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J Neuropathol Exp Neurol 68:159-167.
84. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
85. Kriz J, Nguyen MD, Julien JP. 2002. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10:268-278.
86. Lalancette-Hébert M, Gowing G, Simard A, Weng YC, Kriz J. 2007. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27:2596-2605.
87. Lauro C, Cipriani R, Catalano M, Trettel F, Chece G, Brusadin V, Antonilli L, van Rooijen N, Eusebi F, Fredholm BB, Limatola C. 2010. Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology 35:1550-1559.
88. Le Marrec-Croq F, Drago F, Vizioli J, Sautière PE, Lefebvre C. 2013. The leech nervous system: A valuable model to study the microglia involvement in regenerative processes. Clin Dev Immunol 2013:274019.
89. Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, Nitsch R, Weber JR. 2008. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 28:2320-2331.
90. Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML. 2010. Reactive microgliosis: Extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 133:808-821.
91. Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. 2012. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol 237:147-152.
92. Lindia JA, McGowan E, Jochnowitz N, Abbadie C. 2005. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain 6:434-438.
93. Linnartz B, Wang Y, Neumann H. 2010. Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation. Int J Alzheimers Dis doi:pii: 587463. 10.4061/2010/587463.
94. Lobsiger CS, Boillee S, McAlonis-Downes M, Khan AM, Feltri ML, Yamanaka K, Cleveland DW. 2009. Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci USA 106:4465-4470. doi: 10.1073/pnas.0813339106.
95. London A, Cohen M, Schwartz M. 2013. Microglia and monocyte-derived macrophages: Functionally distinct populations that act in concert in CNS plasticity and repair. Front Cell Neurosci 8;7:34.
96. Luo XG, Ding JQ, Chen SD. 2010. Microglia in the aging brain: Relevance to neurodegeneration. Mol Neurodegen 5:12.
97. Ma L, Morton AJ, Nicholson LF. 2003. Microglia density decreases with age in a mouse model of Huntington's disease. Glia 43:274-280.
98. Maher FO, Martin DS, Lynch MA. 2004. Increased IL-1beta in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase. Neurobiol Aging 25:795-806.
99. Maiorino C, Khorooshi R, Ruffini F, Lobner M, Bergami A, Garzetti L, Martino G, Owens T, Furlan R. 2013. Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia. Gene Therapy 20:487-496.
100. Mantovani A, Sica A, Locati M. 2005. Macrophage polarization comes of age. Immunity 23:344-346.
101. Melief J, Koning N, Schuurman KG, Van De Garde MD, Smolders J, Hoek RM, Van Eijk M, Hamann J, Huitinga I. 2012. Phenotyping primary human microglia: Tight regulation of LPS responsiveness. Glia 60:1506-1517.
102. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris AM, Biran G, Raffard B, Brochet MH, Canron JM, Franconi C, Boiziau, Petry KG. 2011. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 17:2-15.
103. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Brück W, Priller J, Prinz M. 2007. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 10:1544-1553.
104. Mildner A, Mack M, Schmidt H, Brück W, Djukic M, Zabel MD, Hille A, Priller J, Prinz M. 2009. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 132:2487-2500.
105. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJ, ffrench-Constant C. 2013. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211-1218.
106. Mirrione MM, Konomos DK, Gravanis I, Dewey SL, Aguzzi A, Heppner FL, Tsirka SE. 2010. Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice. Neurobiol Dis 39:85-97.
107. Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, Cardona AE. 2012. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol 188:29-36.
108. Montero Domínguez M, González B, Zimmer J. 2009. Neuroprotective effects of the anti-inflammatory compound triflusal on ischemia-like neurodegeneration in mouse hippocampal slice cultures occur independent of microglia. Exp Neurol 218:11-23.
109. Montero M, Gonzalez B, Zimmer J. 2009. Immunotoxic depletion of microglia in mouse hippocampal slice cultures enhances ischemia-like neurodegeneration. Brain Res 1291:140-152.
110. Morganti JM, Nash KR, Grimmig BA, Ranjit S, Small B, Bickford PC, Gemma C. 2012. The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. J Neurosci 32:14592-14601.
111. Nadeau S, Rivest S. 2002. Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: Role of glucocorticoids and CD14. J Immunol 169:3370-3381.
112. Nadeau S, Rivest S. 2003. Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci 23:5536-5544.
113. Neher JJ, Emmrich JV, Fricker M, Mander PK, Théry C, Brown GC. 2013. Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc Natl Acad Sci USA 110:E4098-E4107. doi: 10.1073/pnas.1308679110.
114. Neumann H, Wekerle H. 2013. Brain microglia: Watchdogs with pedigree. Nat Neurosci 16:253-255.
115. Nijboer CH, Heijnen CJ, Willemen HL, Groenendaal F, Dorn GW II, van Bel F, Kavelaars A. 2010. Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice. Brain Behav Immun 24:420-426.
116. Njie EG, Boelen E, Stassen FR, Steinbusch HW, Borchelt DR, Streit WJ. 2012. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging 33:195.e1-e12.
117. Nolan Y, Maher FO, Martin DS, Clarke RM, Brady MT, Bolton AE, Mills KH, Lynch MA. 2005. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem 280:9354-9362.
118. Norden DM, Godbout JP. 2013. Review: Microglia of the aged brain: Primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 39:19-34.
119. O'Callaghan JP, Sriram K, Miller DB. 2008. Defining "neuroinflammation". Ann NY Acad Sci 1139:318-330.
120. Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M. 2006. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice. Neurosci Lett 401:183-187.
121. Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, Boddeke HW. 2012. Identification of a microglia phenotype supportive of remyelination. Glia 60:306-321.
122. Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC. 2011. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J Neuroinflammation 25;8:9.
123. Pais TF, Figueiredo C, Peixoto R, Braz MH, Chatterjee S. 2008. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J Neuroinflammation 9;5:43.
124. Parkhurst CN, Gan WB. 2010. Microglia dynamics and function in the CNS. Curr Opin Neurobiol 20:595-600.
125. Perry VH. 2007. Stress primes microglia to the presence of systemic inflammation: Implications for environmental influences on the brain. Brain Behav Immun 21:45-46.
126. Pfrieger FW, Slezak M. 2012. Genetic approaches to study glial cells in the rodent brain. Glia 60:681-701.
127. Phinney AL, Andringa G, Bol JG, Wolters EC, Muiswinkel FL, Dam AM, Drukarch B. 2006. Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging. Parkinsonism Relat Disord 12:228-238.
128. Prinz M, Mildner A. 2011. Microglia in the CNS: Immigrants from another world. Glia 59:177-187.
129. Prinz M, Priller J, Sisodia SS, Ransohoff RM. 2011. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 14:1227-1235.
130. Qin H, Yeh WI, De Sarno P, Holdbrooks AT, Liu Y, Muldowney MT, Reynolds SL, Yanagisawa LL, Fox TH III, Park K, Harrington LE, Raman C, Benveniste EN. 2012. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc Natl Acad Sci USA 109:5004-5009.
131. 56Fe radiation on hippocampal function in mice deficient in chemokine receptor 2 (CCR2). Behav Brain Res doi:pii: S0166-4328:00136-00138.
132. Radde R, Duma C, Goedert M, Jucker M. 2008. The value of incomplete mouse models of Alzheimer's disease. Eur J Nucl Med Mol Imaging Suppl 1:S70-S74. doi: 10.1007/s00259-007-0704-y.
133. Ransohoff RM, Cardona AE. 2010. The myeloid cells of the central nervous system parenchyma. Nature 468:253-262.
134. Ransohoff RM, Perry VH. 2009. Microglial physiology: Unique stimuli, specialized responses. Annu Rev Immunol 27:119-145.
135. Ransohoff RM, Prinz M. 2013. Editors' preface: Microglia-A new era dawns. Glia 61:1-2. doi: 10.1002/glia.22439.
136. Rodríguez JJ, Olabarria M, Chvatal A, Verkhratsky A. 2009. Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16:378-385.
137. Rodríguez JJ, Olabarria M, Chvatal A, Verkhratsky A. 2009. Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16:378-385.
138. Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM, Charo IF. 2010. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One doi: 10.1371/journal.pone.0013693.
139. Schilling M, Strecker JK, Ringelstein EB, Schäbitz WR, Kiefer R. 2009. The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice. Brain Res 1289:79-84.
140. Schilling M, Strecker JK, Schäbitz WR, Ringelstein EB, Kiefer R. 2009. Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 161:806-812.
141. Schmid CD, Melchior B, Masek K, Puntambekar SS, Danielson PE, Lo DD, Sutcliffe JG, Carson MJ. 2009. Differential gene expression in LPS/IFNgamma activated microglia and macrophages: In vitro versus in vivo. J Neurochem 109:117-125.
142. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F. 2012. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336:86-90.
143. Sieger D, Peri F. 2013. Animal models for studying microglia: the first, the popular, and the new. Glia 61:3-9.
144. Sierra A, Abiega O, Shahraz A, Neumann H. 2013. Janus-faced microglia: Beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci 30;7:6.
145. Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. 2007. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55:412-424.
146. Sonetti D, Peruzzi E. 2004. Neuron-microglia communication in the CNS of the freshwater snail Planorbarius corneus. Acta Biol Hung 55:273-285.
147. Sonetti D, Ottaviani E, Bianchi F, Rodriguez M, Stefano ML, Scharrer B, Stefano GB. 1994. Microglia in invertebrate ganglia. Proc Natl Acad Sci USA 91:9180-9184.
148. Streit WJ. 2006. Microglial senescence: Does the brain's immune system have an expiration date? Trends Neurosci 29:506-510.
149. Streit WJ. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139.
150. Streit WJ, Braak H, Xue QS, Bechmann I. 2009. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 118:475-485.
151. Sugama S, Yang L, Cho BP, DeGiorgio LA, Lorenzl S, Albers DS, Beal MF, Volpe BT, Joh TH. 2003. Age-related microglial activation in 1-methyl-4-phenyl- 1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res 964:288-294.
152. Takahashi K, Rochford CD, Neumann H. 2005. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 201:647-657.
153. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M. 2002. Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci 15:1663-1668.
154. Tasiemski A, Salzet M. 2010. Leech immunity: From brain to peripheral responses. Adv Exp Med Biol 708:80-104.
155. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. 2001. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580-2588.
156. Tremblay MÈ, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. 2011. The role of microglia in the healthy brain. J Neurosci 31:16064-16069.
157. Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, Yamashita T. 2013. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci doi: 10.1038/nn.3358.
158. van Rossum D, Hanisch UK. 2004. Microglia. Metab Brain Dis 19(3-4):393-411.
159. van Weering HR, Boddeke HW, Vinet J, Brouwer N, de Haas AH, van Rooijen N, Thomsen AR, Biber KP. 2011. CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus 21:220-232.
160. Varvel NH, Grathwohl SA, Baumann F, Liebig C, Bosch A, Brawek B, Thal DR, Charo IF, Heppner FL, Aguzzi A, Garaschuk O, Ransohoff RM, Jucker M. 2012. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proc Natl Sci Acad USA 109:18150-18155.
161. Vinet J, Weering HR, Heinrich A, Kälin RE, Wegner A, Brouwer N, Heppner FL, Rooijen Nv, Boddeke HW, Biber K. 2012. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J Neuroinflammation 9:27.
162. Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue LF. 2009. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation. Exp Neurol 215:5-19.
163. Willemen HL, Eijkelkamp N, Wang H, Dantzer R, Dorn GW II, Kelley KW, Heijnen CJ, Kavelaars A. 2010. Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: Contribution of spinal cord CX3CR1, p38 and IL-1 signaling. Pain 150:550-560.
164. Wolf Y, Yona S, Kim KW, Jung S. 2013. Microglia, seen from the CX3CR1 angle. Front Cell Neurosci 7:26.
165. Wong E, Cuervo AM. 2010. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 7:805-811.
166. Wynne AM, Henry CJ, Huang Y, Cleland A, Godbout JP. 2010. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav Immun 24:1190-1201.
167. Xu Y, Zeng K, Han Y, Wang L, Chen D, Xi Z, Wang H, Wang X, Chen G. 2012. Altered expression of CX3CL1 in patients with epilepsy and in a rat model. Am J Pathol 180:1950-1962.
168. Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, Ikezu T. 2007. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol 170:680-692.
169. Yao Y, Tsirka SE. 2012. The CCL2-CCR2 system affects the progression and clearance of intracerebral hemorrhage. Glia 60:908-918.
170. Yi MH, Zhang E, Kang JW, Shin YN, Byun JY, Oh SH, Seo JH, Lee YH, Kim DW. 2012. Expression of CD200 in alternative activation of microglia following an excitotoxic lesion in the mouse hippocampus. Brain Res 1481:90-96.
171. Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, Hume DA, Perlman H, Malissen B, Zelzer E, Jung S. 2013. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38:79-91.
172. Yong VW, Rivest S. 2009. Taking advantage of the systemic immune system to cure brain diseases. Neuron 64:55-60.
173. Yrjänheikki J, Keinänen R, Pellikka M, Hökfelt T, Koistinaho J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769-15774.
174. Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S. 2007. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 27:12396-12406.
175. Zuurman MW, Heeroma J, Brouwer N, Boddeke HW, Biber K. 2003. LPS-induced expression of a novel chemokine receptor (L-CCR) in mouse glial cells in vitro and in vivo. Glia 41:327-336.